LP-DG® is a premium probiotic strain backed by years of research
and creative inspiration by SOFAR S.p.A., Italy’s leading digestive health company.
In the early 90s, SOFAR identifies and acquires the probiotic strain LP-DG® (Lactobacillus paracasei CNCM I-1572) for its specific anti-inflammatory and gut-modulating properties as well as for its marked ability withstand various stresses, such as the crossing of the gastric environment, and characterized by strong vitality, able to quickly rebalance the composition of the intestinal flora.
In the late 90s, first probiotic supplement containing LP-DG® strain is launched in the Italian market and in 2017 the product becomes number 1 dietary supplement in Italy.
In 2018, LP-DG® strain is available in a number of products worldwide, through SOFAR branches or licensees.
SOFAR remains committed to deliver scientifically proven, stable, innovative products based on LP-DG® strain.
Part of the information contained in this website is exclusively addressed to healthcare professionals. Please confirm that you are a healthcare professional. Are you a healthcare professional?
This website contains links/references to third-party websites. By such links, SOFAR does not provide any guarantee nor gives its approval to their contents and quality. SOFAR does not have and does not accept any responsibility for the contents or the availability of such websites; SOFAR does not accept any liability for damage or injury resulting from the use of such contents, of whatever form. Users access such websites at their own risk. The information contained in this website is for information purposes only and not for diagnostic or therapeutic purposes. Thus, it does not substitute in any way medical and /or expert or other healthcare professionals or specialists ‘advice.